CardiologyCommons

professional and social network for cardiology

min zhao
  • jinan,shan dong
  • China, mainland
Share on Facebook Share

Min zhao's Friends

  • fayaz mujtaba

min zhao's Groups

 

min zhao's Page

Latest Activity

min zhao and fayaz mujtaba are now friends
May 20, 2011
fayaz mujtaba commented on min zhao's blog post What about in those patients with AF?
"is calcium channel blockers are contraindicated in all patients with low Ef or only those who are in failure or decompensated state."
May 20, 2011
fayaz mujtaba commented on min zhao's blog post ABOUT HF
"in my opinion arb should not be considered as alternative to acei when there are no contraindication to use of former. secondly there is data that losartan actually increases mortality in heart failure patients so it…"
May 20, 2011
min zhao posted blog posts
Mar 9, 2011
min zhao joined CardiologyCommons Team's group
Thumbnail

Cardiac Imaging

Group for all those interested in cardiac imaging (Echo, MR, CT, Nuclear)
Mar 9, 2011
min zhao updated their profile photo
Mar 9, 2011
min zhao is now a member of CardiologyCommons
Mar 9, 2011

Profile Information

Workplace / Organization / Company
kow loon hospital
Profession
cardiac surgeon
Title
dr
Subspecialty and Expertise in Cardiology
cardiac surgery
Undergraduate, Medical School, and Graduate School (Degrees, Major, and Institution)
bei jing univerdity
URL / Website
http://www.ctenet.org/home/mzhao
Interests
everything

Min zhao's Blog

Losartan TREATMENT HF

Reascher:In my opinion, at this time Losartan 150 mg is much better than 50 mg in terms of the edendpoints. There is a 10% decrease with 150 mg of Losartan in terms of reducing death or heart failure hospitalization. The HEAALstudy is the first to verify that 150 mg of Losartan has a therapeutic effect in the treatment of heart failure. Also, in Chinathe first time RAS blockade used to treat heart failure were ACE inhibitors but we have about 20% of patients with coughafter…

Continue

Posted on March 9, 2011 at 8:00pm

ABOUT HF

Reascher:I’d like to talk today about heart failure specifically. We have seen several lead breaking heart failure trials presented here at AHA 2009 and one of those trials was the HEAAL study. Can you give us your brief opinion on the HEAAL study as well as any comments about how we can evaluate it? Additionally, what do you think the contribution is to the progress regarding how we can treat heart failure?

 Prof. Nissen:We don’t use Losartan very…

Continue

Posted on March 9, 2011 at 8:00pm — 1 Comment

What about in those patients with AF?

Reascher:What about in those patients with AF?

 

Prof. Jessup : Physicians often times use the wrong drugs to slow heart rate or they may combine a calcium antagonist drug in someone who has a poor ejection fraction and that is the wrong thing to do. I think that the guidelines that came out today are very helpful.

Posted on March 9, 2011 at 7:59pm — 1 Comment

What is the most efficient or best way to screen out patients who are at high risk for heart failure?

Reascher:What is the most efficient or best way to screen out patients who are at high risk for heart failure?

 

Prof. Jessup : In general physicians do understand who is at high risk. High-risk patients include patients in the hospital frequently, those with an elevated BUN and creatinine, patients with low blood pressure, or multiple comorbidities, which this session was about. Most physicians will understand those patients to be high risk but do not necessarily act on that…

Continue

Posted on March 9, 2011 at 7:57pm

Comment Wall (1 comment)

At 8:14am on December 17, 2012, pauline atta said…


Hello Dear,

How is everything with you,I picked interest on you after going through your short profile and deemed it necessary to write you immediately.I have something very vital to disclose to you,but I found it difficult to express myself here,since it's a public site.Could you please get back to me on(pauline120atta@yahoo.co.th)for the full details.
Have a nice day.

thanks
Pauline Atta.

You need to be a member of CardiologyCommons to add comments!

Join CardiologyCommons

 
 
 

© 2017   Created by CardiologyCommons Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service